Glioblastoma multiforme (GBM) is the most common type of aggressive malignant brain cancer. The current lack of successful therapeutics means that this disease has a dismal prognosis. However, a new study in mice offers hope for patients with GBM by demonstrating the efficacy of a novel drug that targets GBM-associated macrophages (pages 1264–1272).
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Dual Role of WISP1 in maintaining glioma stem cells and tumor-supportive macrophages in glioblastoma
Nature Communications Open Access 15 June 2020
-
ARS2/MAGL signaling in glioblastoma stem cells promotes self-renewal and M2-like polarization of tumor-associated macrophages
Nature Communications Open Access 12 June 2020
-
Tumour-associated macrophages secrete pleiotrophin to promote PTPRZ1 signalling in glioblastoma stem cells for tumour growth
Nature Communications Open Access 01 June 2017
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Hanahan, D. & Weinberg, R.A. Cell 144, 646–674 (2011).
Pyonteck, S.M. et al. Nat. Med. 19, 1264–1272 (2013).
Qian, B.-Z. & Pollard, J.W. Cell 141, 39–51 (2010).
DeNardo, D.G. et al. Cancer Discov. 1, 54–67 (2011).
Zhang, B.C. et al. Med. Oncol. 28, 1447–1452 (2011).
Steidl, C. et al. N. Engl. J. Med. 362, 875–885 (2010).
Hume, D.A. & MacDonald, K.P.A. Blood 119, 1810–1820 (2012).
Lin, E.Y., Nguyen, A.V., Russell, R.G. & Pollard, J.W. J. Exp. Med. 193, 727–740 (2001).
Biswas, S.K. & Mantovani, A. Nat. Immunol. 11, 889–896 (2010).
Porta, C. et al. Proc. Natl. Acad. Sci. USA 106, 14978–14983 (2009).
Hagemann, T. et al. J. Exp. Med. 205, 1261–1268 (2008).
Spence, S. et al. Immunity 38, 66–78 (2013).
De Palma, M. & Lewis, C.E. Cancer Cell 23, 277–286 (2013).
Stupp, R. et al. N. Engl. J. Med. 352, 987–996 (2005).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Garris, C., Pittet, M. Therapeutically reeducating macrophages to treat GBM. Nat Med 19, 1207–1208 (2013). https://doi.org/10.1038/nm.3355
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm.3355
This article is cited by
-
Dual Role of WISP1 in maintaining glioma stem cells and tumor-supportive macrophages in glioblastoma
Nature Communications (2020)
-
ARS2/MAGL signaling in glioblastoma stem cells promotes self-renewal and M2-like polarization of tumor-associated macrophages
Nature Communications (2020)
-
An miR-340-5p-macrophage feedback loop modulates the progression and tumor microenvironment of glioblastoma multiforme
Oncogene (2019)
-
Imaging of Tumor-Associated Macrophages in a Transgenic Mouse Model of Orthotopic Ovarian Cancer
Molecular Imaging and Biology (2017)
-
Tumour-associated macrophages secrete pleiotrophin to promote PTPRZ1 signalling in glioblastoma stem cells for tumour growth
Nature Communications (2017)